Kontakta oss

Miyoung Yoon

Miyoung Yoon

Principal

+1 703-516-2344

Arlington, VA

Nyckelkompetenser

Dr. Miyoung Yoon is a Principal in Science to Support Regulatory Activities at Ramboll, with more than 25 years of experience in chemical and pharmaceutical safety and regulatory science. She specializes in physiologically based pharmacokinetic (PBPK) modelling, quantitative in vitro–to–in vivo extrapolation (IVIVE), and the integration of new approach methodologies (NAMs) to support risk assessment and regulatory decisions. At Ramboll she leads chemical and pharmaceutical safety and regulatory assessments, integrating pharmacokinetics and toxicity evidence from NAMs and traditional approaches such as animal studies to produce human‑relevant predictions. She uses mode‑of‑action and adverse outcome pathway (AOP) interpretation to relate multiple streams of evidence to human health, and focuses on practical ways to incorporate in vitro and other NAM data into risk‑assessment workflows. Her senior scientific roles in government, research and consultancy have informed the development of compound‑specific and NAM‑integrated PBPK/IVIVE models for regulatory applications. Dr Yoon’s work is reflected in more than 100 scientific and regulatory publications.